183 related articles for article (PubMed ID: 35665735)
1. The effect of 0.01% atropine on ocular axial elongation for myopia children: A protocol for systematic review and meta-analysis.
Gao Y; Yu Y
Medicine (Baltimore); 2022 Jun; 101(22):e29409. PubMed ID: 35665735
[TBL] [Abstract][Full Text] [Related]
2. The effect of 0.01% atropine and orthokeratology on ocular axial elongation for myopia children: A meta-analysis (a PRISMA-compliant article).
Yu Y; Liu J
Medicine (Baltimore); 2022 May; 101(18):e29191. PubMed ID: 35550467
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis.
Wang Z; Wang P; Jiang B; Meng Y; Qie S; Yan Z
PLoS One; 2023; 18(7):e0282286. PubMed ID: 37494360
[TBL] [Abstract][Full Text] [Related]
4. The Efficacy of Atropine Combined With Orthokeratology in Slowing Axial Elongation of Myopia Children: A Meta-Analysis.
Gao C; Wan S; Zhang Y; Han J
Eye Contact Lens; 2021 Feb; 47(2):98-103. PubMed ID: 33060414
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the long-term effects of atropine in combination with Orthokeratology and defocus incorporated multiple segment lenses for myopia control in Chinese children and adolescents.
Tang T; Lu Y; Li X; Zhao H; Wang K; Li Y; Zhao M
Eye (Lond); 2024 Jun; 38(9):1660-1667. PubMed ID: 38418604
[TBL] [Abstract][Full Text] [Related]
6. Low concentration atropine combined with orthokeratology in the treatment of axial elongation in children with myopia: A meta-analysis.
Yang N; Bai J; Liu L
Eur J Ophthalmol; 2022 Jan; 32(1):221-228. PubMed ID: 33678055
[TBL] [Abstract][Full Text] [Related]
7. Combined Orthokeratology with Atropine for Children with Myopia: A Meta-Analysis.
Wang S; Wang J; Wang N
Ophthalmic Res; 2021; 64(5):723-731. PubMed ID: 32781450
[TBL] [Abstract][Full Text] [Related]
8. Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial.
Yu S; Du L; Ji N; Li B; Pang X; Li X; Ma N; Huang C; Fu A
BMC Ophthalmol; 2022 Nov; 22(1):438. PubMed ID: 36380280
[TBL] [Abstract][Full Text] [Related]
9. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results.
Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kakehashi A
Jpn J Ophthalmol; 2018 Sep; 62(5):544-553. PubMed ID: 29974278
[TBL] [Abstract][Full Text] [Related]
10. Two-year add-on effect of using low concentration atropine in poor responders of orthokeratology in myopic children.
Chen Z; Zhou J; Xue F; Qu X; Zhou X
Br J Ophthalmol; 2022 Aug; 106(8):1069-1072. PubMed ID: 33707188
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children.
Zhao Q; Hao Q
Int Ophthalmol; 2021 Mar; 41(3):1011-1017. PubMed ID: 33205372
[TBL] [Abstract][Full Text] [Related]
12. Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination.
Hao Q; Zhao Q
Int Ophthalmol; 2021 Sep; 41(9):2963-2971. PubMed ID: 33954859
[TBL] [Abstract][Full Text] [Related]
13. Higher order aberrations and axial elongation in combined 0.01% atropine with orthokeratology for myopia control.
Vincent SJ; Tan Q; Ng ALK; Cheng GPM; Woo VCP; Cho P
Ophthalmic Physiol Opt; 2020 Nov; 40(6):728-737. PubMed ID: 32888318
[TBL] [Abstract][Full Text] [Related]
14. The synergistic efficacy and safety of combined low-concentration atropine and orthokeratology for slowing the progression of myopia: A meta-analysis.
Zheng NN; Tan KW
Ophthalmic Physiol Opt; 2022 Nov; 42(6):1214-1226. PubMed ID: 35919929
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive effects of orthokeratology and atropine 0.01% eye drops on slowing the progression of myopia.
Zhou H; Zhao G; Li Y
Clin Exp Optom; 2022 Jul; 105(5):520-526. PubMed ID: 34228946
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial.
Yuan Y; Zhu C; Liu M; Zhou Y; Yang X; Zheng B; Li Z; Mao X; Ke B
Trials; 2021 Dec; 22(1):863. PubMed ID: 34852833
[TBL] [Abstract][Full Text] [Related]
17. Combined Atropine with Orthokeratology for Myopia Control: Study Design and Preliminary Results.
Tan Q; Ng AL; Cheng GP; Woo VC; Cho P
Curr Eye Res; 2019 Jun; 44(6):671-678. PubMed ID: 30632410
[No Abstract] [Full Text] [Related]
18. Overnight orthokeratology is comparable with atropine in controlling myopia.
Lin HJ; Wan L; Tsai FJ; Tsai YY; Chen LA; Tsai AL; Huang YC
BMC Ophthalmol; 2014 Mar; 14():40. PubMed ID: 24685184
[TBL] [Abstract][Full Text] [Related]
19. Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial.
Tan Q; Ng AL; Cheng GP; Woo VC; Cho P
Cont Lens Anterior Eye; 2023 Feb; 46(1):101723. PubMed ID: 35654683
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial.
Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kaburaki T; Kakehashi A
Sci Rep; 2020 Jul; 10(1):12750. PubMed ID: 32728111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
